#biopharma — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #biopharma, aggregated by home.social.
-
After full approval, Sarepta lays out its next moves—Zealand Pharma brings in $1B to drive development of obesity drugs —Sanofi seeks initial offers for Its $20 billion consumer arm—http://bit.ly/w28kSd #sareptatherapeutics #dmd #obesity #zealandpharma #funding #consumerhealth #sanofi #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
After full approval, Sarepta lays out its next moves—Zealand Pharma brings in $1B to drive development of obesity drugs —Sanofi seeks initial offers for Its $20 billion consumer arm—http://bit.ly/w28kSd #sareptatherapeutics #dmd #obesity #zealandpharma #funding #consumerhealth #sanofi #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
After full approval, Sarepta lays out its next moves—Zealand Pharma brings in $1B to drive development of obesity drugs —Sanofi seeks initial offers for Its $20 billion consumer arm—http://bit.ly/w28kSd #sareptatherapeutics #dmd #obesity #zealandpharma #funding #consumerhealth #sanofi #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Alphabet's quantum spinoff starts working with AstraZeneca, Sanofi to accelerate R&D — Is this a sign that Leqembi could obtain FDA approval next month? -- Sarepta prices Duchenne gene therapy at $3.2M -- See more on our front page news http://bit.ly/w28kSd #alphabet #artificialintelligence #ai #astrazeneca #sanofi #researchanddevelopment #drugdiscovery #alzheimers #biogen #eisai #fda #genetherapy #dmd #sareptatherapeutics #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
FTC probes Abbott for allegedly colluding on bids for state contracts — FDA delays decision on Duchenne gene therapy and considers narrower approval --How Vivek Ramaswamy helped make Martin Shkreli the ‘pharma bro’ -- See more on our front page news http://bit.ly/w28kSd #FTC #collusion #statecontracts #abbottlabs #fda #DMD #sareptatherapeutics #vivekramaswamy #martinshkreli #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma